[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614211":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":26,"locations":35,"responsibleParty":50,"collaborators":23,"id":54,"slug":23,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":23,"eligibilityCriteria":59,"healthyVolunteers":60,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":23,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":38,"whyStopped":23,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Zagazig University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Retrosuperior costotransverse ligament block group","ACTIVE_COMPARATOR","The patient will receive retrosuperior costotransverse ligament block",[13],"Procedure: Retrosuperior costotransverse ligament block group",{"label":15,"type":10,"description":16,"interventionNames":17},"Erector spinae block group","The patient will receive erector spinae block.",[18],"Procedure: Erector spinae block group",[20,24],{"type":21,"name":9,"description":11,"armGroupLabels":22,"otherNames":23},"PROCEDURE",[9],null,{"type":21,"name":15,"description":16,"armGroupLabels":25,"otherNames":23},[15],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":23},"Dina Salem, MD","CONTACT","01099333513","002",{"name":33,"role":29,"phone":34,"phoneExt":31,"email":23},"Marwa Medhat, MD","01002828937",[36],{"facility":37,"status":38,"city":39,"state":23,"zip":23,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Faculty of human medicine, Zagazig university, Zagazig","RECRUITING","Zagazig","Egypt",{"type":42,"coordinates":43},"Point",[44,45],31.502,30.58768,{"lat":45,"lon":44},[48],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":49},"dinamaghraby@yahoo.com",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Dina Abdelhameed Elsadek Salem","Associate professor","100614211",false,"NCT07276646","Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy","Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy: A Randomized Clinical Trial.","Inclusion Criteria:\n\n1. patient acceptance\n2. Age: 21-64 years old.\n3. Sex: both sexes.\n4. Physical status: ASA I \\& II.\n5. Body mass index (BMI): 18.5 - 30 kg\u002Fm2.\n6. Type of operations: elective laparoscopic cholecystectomy.\n7. Duration of surgery not more than 2 hours.\n\nExclusion Criteria:\n\n1. Known hypersensitivity to lidocaine or bupivacaine.\n2. Patients with respiratory insufficiency.\n3. Coagulation disorders or taking drugs affect surgical hemostasis.\n\n7\\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases",true,"ALL","21 Years","64 Years",{"count":65,"type":66},80,"ESTIMATED","INTERVENTIONAL",[69],"NA","This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction",[72],"Perioperative Analgesia",[74,75,76],"retrosuperior costotransverse ligament block","erector spinae block","laparoscopic cholecystectomy","2025-12-11",{"date":79,"type":80},"2025-12-12","ACTUAL",{"date":82,"type":80},"2025-12-10",{"date":84,"type":66},"2026-07-10",{"name":5,"class":6},1]